Axovant Sciences Ltd. 4
4 · Axovant Sciences Ltd. · Filed Jun 16, 2017
Insider Transaction Report
Form 4
Mohr Stephen Frederick
General Counsel
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-06-15+187,400→ 187,400 totalExercise: $20.72Exp: 2027-06-14→ Common Shares (187,400 underlying)
Footnotes (1)
- [F1]25% of the common shares underlying the option vest and become exercisable on May 30, 2018; the balance of the common shares vest in a series of 12 successive equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Vesting is subject to acceleration in specified circumstances, including a change in control of the Issuer or the Reporting Person's termination without cause or resignation for good reason.